Our experiments showed that the inhibition of HSP-associated GRPEL2 expression led to OXPHOS dysfunction, eliciting the intracellular ROS decrease, thereby retarding GBM cell proliferation. The gene discussed is HSP90B2P; the disease is glioblastoma.